calendar
32,762 catalysts · 13,125 approval · 5,000 device 510k · 4,728 grant · 3,118 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
32,762 catalysts · 13,125 approval · 5,000 device 510k · 4,728 grant · 3,118 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION
Sponsor: INVAGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: SANDOZ INC. Form: FOR SUSPENSION. Route: ORAL
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: GENUS. Form: SOLUTION. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SOLUTION. Route: ORAL
Sponsor: GRANULES INDIA. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: ORGANON. Form: IMPLANT. Route: IMPLANTATION
Sponsor: APOTEX INC. Form: CAPSULE. Route: ORAL
Sponsor: PH HEALTH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: TAKEDA PHARMS USA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: SANDOZ. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: ZYDUS PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL
Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: LUPIN. Form: CAPSULE. Route: ORAL
Sponsor: LUPIN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: ZYDUS PHARMS USA INC. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL
Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL